Latest Updates

Is Section 84(1)(b) of The Patents Act of India in danger? A scrupulous analysis by Milind Sathe

Will join office on June 1, 2013

Enters into an in-licensing business agreement with Alembic

The offer will be implemented via a scheme of arrangement

Cuts could threaten the future of medical research: GlobalData analysis

Committed to addressing analytical science challenges within South East Asia for pharmaceutical, food, environmental and chemical…

To sell it for an aggregate sum of $1,600 million in cash and potential additional consideration of up to $250 million

Event to be held at Ahmedabad from April 5-6, 2013

Attended by over 40 senior sales, marketing, training, commercial, and business executives from leading global and Indian pharma…

Event to be held in Mumbai on May8-10, 2013